Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adage Capital Management Ups Stake in Five Prime Therapeutics Inc (FPRX)

Page 1 of 2

In a new filing with the U.S. Securities and Exchange Commission, Adage Capital Management, managed by Phill Gross and Robert Atchinson, has disclosed a passive stake in Five Prime Therapeutics Inc (NASDAQ:FPRX). According to the filing, Adage Capital Management holds 1.52 million Five Prime Therapeutics Inc (NASDAQ:FPRX) shares, which represents a significant increase from 500,000 shares the hedge fund reported in its 13F filing. The new stake is equivalent to 6.09% of the company’s common stock.

Phill Gross Adage Capital Management

Adage Capital Management is a Boston-based hedge fund founded by Phill Gross and Robert Atchinson in 2001. Previously, Gross was a healthcare and retail analyst at Jane Mendillo’s Harvard Management Company (HMC). Later, Gross became a partner at HMC, where he spent 18 years. Atchinson also worked at the Harvard Management Company from 1991 to 2001.

Adage Capital Management has a highly diversified equity portfolio, worth more than $40 billion. The fund’s three most favorite holdings include Puma Biotechnology Inc (NYSE:PBYI), Apple Inc. (NASDAQ:AAPL), and Shire PLC (ADR)(NASDAQ:SHPG). As of the end of the third quarter, the fund revealed ownership of 5.69 million shares of Puma Biotechnology Inc (NYSE:PBYI), equal to 3.35% of the fund’s portfolio. Adage Capital Management reported owning 9.12 million Apple Inc. (NASDAQ:AAPL) shares, the stake represents 3% decrease over the quarter. The fund’s third most valuable is represented by Shire PLC (ADR)(NASDAQ:SHPG) a new position, in which the fund disclosed holding 3.27 million of Shire PLC (ADR)(NASDAQ:SHPG).

Last month, Adage Capital Management reported upping its exposure to Pacific Drilling SA (NYSE:PACD) by more than 12%. In a new filing, the fund disclosed owing 11.45 million common shares, accounting for 5.27% of the company’s outstanding stock. In November, Adage Capital Partners reported upping its stake in Rexnord Corp (NYSE:RXN), holding 5.37 million shares of the company, the passive stake amasses 5.28% of common stock. Earlier, the fund held 2.52 million shares of the company.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!